Krystal Biotech, Inc. - COMMON STOCK (KRYS)

Historical Holders from Q3 2017 to Q3 2025

Symbol
KRYS on Nasdaq
CUSIP
501147102
Type / Class
Equity / COMMON STOCK
Shares outstanding
29.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
28M
Holdings value
$4.94B
% of all portfolios
0.006%
Grand Portfolio weight change
+0%
Number of holders
280
Number of buys
147
Number of sells
-119
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Krystal Biotech, Inc. - COMMON STOCK (KRYS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STATE STREET CORP 4.4% $219M 1.28M STATE STREET CORPORATION Dec 31, 2024

Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 28M $4.94B +$83.5M $176.53 280
2025 Q2 27.7M $3.8B -$874K $137.46 273
2025 Q1 27.3M $4.93B -$51.2M $180.30 298
2024 Q4 27.8M $4.35B -$54.1M $156.66 263
2024 Q3 28M $5.1B -$100M $182.03 282
2024 Q2 28.5M $5.23B +$661M $183.64 247
2024 Q1 25.2M $4.49B +$195M $177.93 238
2023 Q4 65.8K $8.23M +$4.01M $125.91 2
2023 Q3 23.8M $2.76B +$92.6M $116.00 184
2023 Q2 23M $2.7B +$256M $117.40 179
2023 Q1 21M $1.68B +$9.46M $80.06 156
2022 Q4 20.9M $1.65B -$15.8M $79.22 150
2022 Q3 20.8M $1.45B +$2.33M $69.70 136
2022 Q2 20.8M $1.36B +$17.5M $65.66 127
2022 Q1 20.3M $1.35B +$79.5M $66.54 124
2021 Q4 19.1M $1.34B +$208M $69.95 133
2021 Q3 16.3M $851M -$12M $52.21 112
2021 Q2 15.6M $1.06B -$6.34M $68.00 112
2021 Q1 16.5M $1.27B +$170M $77.04 113
2020 Q4 12.7M $760M -$25.5M $60.00 103
2020 Q3 14.4M $619M +$11.3M $43.05 97
2020 Q2 14.1M $582M +$106M $41.42 105
2020 Q1 11.5M $496M -$10.5M $43.24 86
2019 Q4 11.4M $631M +$15.8M $55.38 89
2019 Q3 11.2M $388M +$48.4M $34.73 81
2019 Q2 9.76M $393M +$131M $40.27 73
2019 Q1 6.65M $219M +$15.5M $32.90 56
2018 Q4 6.21M $129M +$67.9M $20.78 45
2018 Q3 2.09M $36.6M -$4.98M $17.57 20
2018 Q2 2.39M $35.5M -$7.83M $14.87 15
2018 Q1 3.08M $31M -$1.63M $10.09 12
2017 Q4 3.24M $34M +$1.03M $10.52 13
2017 Q3 3.14M $31.3M +$31.3M $9.97 13